Success Metrics

Clinical Success Rate
88.0%

Based on 81 completed trials

Completion Rate
88%(81/92)
Active Trials
10(7%)
Results Posted
32%(26 trials)
Terminated
11(8%)

Phase Distribution

Ph phase_2
24
17%
Ph early_phase_1
1
1%
Ph phase_1
8
6%
Ph phase_3
47
33%
Ph phase_4
43
30%
Ph not_applicable
14
10%

Phase Distribution

9

Early Stage

24

Mid Stage

90

Late Stage

Phase Distribution137 total trials
Early Phase 1First-in-human
1(0.7%)
Phase 1Safety & dosage
8(5.8%)
Phase 2Efficacy & side effects
24(17.5%)
Phase 3Large-scale testing
47(34.3%)
Phase 4Post-market surveillance
43(31.4%)
N/ANon-phased studies
14(10.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.1%

81 of 93 finished

Non-Completion Rate

12.9%

12 ended early

Currently Active

10

trials recruiting

Total Trials

141

all time

Status Distribution
Active(21)
Completed(81)
Terminated(12)
Other(27)

Detailed Status

Completed81
unknown27
Terminated11
Not yet recruiting9
Recruiting6
Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials
141
Active
10
Success Rate
88.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.7%)
Phase 18 (5.8%)
Phase 224 (17.5%)
Phase 347 (34.3%)
Phase 443 (31.4%)
N/A14 (10.2%)

Trials by Status

unknown2719%
active_not_recruiting43%
withdrawn11%
enrolling_by_invitation21%
completed8157%
not_yet_recruiting96%
recruiting64%
terminated118%

Recent Activity

Clinical Trials (141)

Showing 20 of 141 trialsScroll for more
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07528417Phase 2

Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)

Not Yet Recruiting
NCT03828201Phase 2

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Active Not Recruiting
NCT06568484Phase 2

Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB

Not Yet Recruiting
NCT06494072Phase 4

Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Recruiting
NCT02701608Phase 3

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

Completed
NCT07320534Phase 4

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

Not Yet Recruiting
NCT04951986Phase 3

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis

Active Not Recruiting
NCT03594149Phase 3

Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

Completed
NCT05079620Phase 4

Early Antibiotics After Aspiration in ICU Patients

Terminated
NCT07229755Phase 2

Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria

Completed
NCT03850379Phase 2

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

Completed
NCT07198685Not Applicable

6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

Not Yet Recruiting
NCT07150065Phase 2

Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever

Completed
NCT06649721Phase 3

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort

Active Not Recruiting
NCT07126639Not Applicable

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Not Yet Recruiting
NCT04502095Phase 4

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Completed
NCT07021729Phase 4

Comparison of Two Treatment Regimens of Helicobacter Pylori Infection

Not Yet Recruiting
NCT06915688Not Applicable

A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations

Not Yet Recruiting
NCT06081361Phase 3

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
141